AERx iDMS pulmonary insulin: Phase III data
Interim 12-month results from a Phase III trial of AERx iDMS pulmonary insulin showed delayed post-meal plasma glucose suppression in
Gathering data...
Interim 12-month results from a Phase III trial of AERx iDMS pulmonary insulin showed delayed post-meal plasma glucose suppression in